Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria
Open Access
- 15 February 2021
- journal article
- research article
- Published by Ecancer Global Foundation in ecancermedicalscience
Abstract
Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria Omolola Salako1, Kehinde ShKeywords
This publication has 33 references indexed in Scilit:
- Colony-Stimulating Factors for Febrile Neutropenia during Cancer TherapyThe New England Journal of Medicine, 2013
- Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapyBreast Cancer Research and Treatment, 2013
- Cancer incidence in Nigeria: A report from population-based cancer registriesCancer Epidemiology, 2012
- 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumoursEuropean Journal of Cancer, 2011
- Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia StudySupportive Care in Cancer, 2010
- Advances in the treatment of neutropeniaCurrent Opinion in Supportive & Palliative Care, 2009
- Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia studySupportive Care in Cancer, 2008
- Logistic regression analysis for febrile neutropenia (FN) induced by docetaxel in Japanese cancer patientsCancer Chemotherapy and Pharmacology, 2007
- Risk Models for Predicting Chemotherapy-Induced NeutropeniaThe Oncologist, 2005
- Granulocyte Colony-Stimulating Factor in Severe Chemotherapy-Induced Afebrile NeutropeniaThe New England Journal of Medicine, 1997